Literature DB >> 1352080

Prolonged QT interval in neonates: benign, transient, or prolonged risk of sudden death.

E Villain1, M Levy, J Kachaner, A Garson.   

Abstract

To determine the factors relating to prognosis, the records of 15 neonates with persistent prolongation of the QT interval on the electrocardiogram after the fourth day of life were reviewed. Patients were admitted for symptoms (syncope, cardiac failure, or seizures), abnormal auscultation with an irregular heart rate or bradycardia, or because of a family history of a long QT syndrome. All infants had a long QTc, ranging from 0.46 to more than 0.70 second. Eight patients who had a QTc over 0.60 second developed severe ventricular arrhythmias (torsades de pointes, ventricular tachycardia) or second-degree AV block. Twelve of 15 were treated with beta-blocking agents, combined with ventricular pacing in five cases. Four infants died in the first month of life; they all had a very long QT interval and had experienced ventricular arrhythmias and AV block. Six children are still being treated with beta-blocking agents for the long QT syndrome and are doing well. In five infants, electrocardiographic abnormalities were transient and the QT interval returned to normal within 1 year. Therefore (1) prolongation of the QT interval in neonates may be transient or may represent an early form of the long QT syndrome and (2) the length of the QT interval may provide data on prognosis: those with a QTc less than 0.50 second returned to normal; those with a QTc greater than 0.60 second were associated with severe arrhythmias and four of eight infants died.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352080     DOI: 10.1016/0002-8703(92)90940-w

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Authors:  Rose M Viscardi; Ahmed A Othman; Hazem E Hassan; Natalie D Eddington; Elias Abebe; Michael L Terrin; David A Kaufman; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

2.  Genetic variants for long QT syndrome among infants and children from a statewide newborn hearing screening program cohort.

Authors:  Ruey-Kang R Chang; Yueh-Tze Lan; Michael J Silka; Hallie Morrow; Alan Kwong; Janna Smith-Lang; Robert Wallerstein; Henry J Lin
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

3.  Prenatal findings in patients with prolonged QT interval in the neonatal period.

Authors:  M Hofbeck; H Ulmer; E Beinder; E Sieber; H Singer
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

4.  Effects of cisapride on QTc interval in term neonates.

Authors:  D S Semama; S Bernardini; S Louf; B Laurent-Atthalin; J B Gouyon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

5.  Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response.

Authors:  E Schulze-Bahr; H Fenge; D Etzrodt; W Haverkamp; G Mönnig; H Wedekind; G Breithardt; H-G Kehl
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

6.  Perinatal manifestations of idiopathic long QT syndrome.

Authors:  C J Mache; A Beitzke; M Haidvogl; A Gamillscheg; C Suppan; J I Stein
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

7.  Safe Anaesthesia Management in a Child with Congenital Long QT Syndrome.

Authors:  Mustafa Özgür; Ayhan Köseoğlu
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-04-01

Review 8.  Cardiorespiratory events in preterm infants: etiology and monitoring technologies.

Authors:  J M Di Fiore; C F Poets; E Gauda; R J Martin; P MacFarlane
Journal:  J Perinatol       Date:  2015-11-19       Impact factor: 2.521

Review 9.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.